Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)

Antzeko izenburuak

• Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
  nork: Horinouchi, Tomoko, et al.
  Argitaratua: (2018)
• Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
  nork: Nagano, China, et al.
  Argitaratua: (2019)
• A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
  nork: Yoshikawa, Norishige, et al.
  Argitaratua: (2015)
• Rituximab for nephrotic syndrome in children
  nork: Iijima, Kazumoto, et al.
  Argitaratua: (2016)
• Rituximab Treatment for Nephrotic Syndrome in Children
  nork: Iijima, Kazumoto, et al.
  Argitaratua: (2014)